Papers
3
Total Citations
39
H-Index
3
About
Dr. Junyang Lu is a pioneering colorectal surgeon whose research is reshaping the landscape of minimally invasive oncology, with a specific focus on the comparative efficacy of robotic surgical platforms. His work centers on advancing surgical techniques for colorectal and rectal cancer, particularly through rigorous clinical trials evaluating emerging technologies against established standards. Dr. Lu’s major contributions include leading a multicentre randomised controlled noninferiority trial that directly compared the novel KangDuo surgical robot with the da Vinci Xi system for radical colorectal cancer resection, demonstrating comparable short-term outcomes and validating a new, potentially more accessible robotic platform. His influential 2019 systematic review and meta-analysis, which has garnered 16 citations, provided critical evidence on the safety and effectiveness of robotic versus conventional laparoscopic surgery for rectal cancer. Dr. Lu has further extended this research to elderly patients, a traditionally high-risk group, through a dedicated multicenter trial. With a growing citation impact, his work is not only advancing the evidence base for robotic colorectal surgery but also playing a pivotal role in the clinical adoption of innovative, cost-effective surgical technologies in China and beyond.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3